NEVVI Medicare utilization intelligence
or

← back

Provider profile

TOFILON, SARAH MD

Hematology-Oncology · NPI 1003079997 · FORT DODGE, IA

1
Groups
33
Codes · 2024
62,889
Disclosed services

TOFILON, SARAH is a Hematology-Oncology in FORT DODGE, IA, a member of 1 medical group, who billed 33 distinct codes to Medicare Part B in 2024.

Groups: MCFARLAND CLINIC PC (AMES, IA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

62,889
disclosed services
33
codes billed to Medicare Part B
Prior year · CY2023 56,877 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1439 Injection, ferric carboxymaltose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96413 Administration of chemotherapy into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J2405 Injection, ondansetron hydrochloride, per 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9045 Injection, carboplatin, 50 mg
96375 Injection of additional new drug or substance into vein
96372 Injection of drug or substance under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96411 Administration of additional new drug or substance into vein using push technique
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7030 Infusion, normal saline solution , 1000 cc
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3490 Unclassified drugs
96360 Infusion into a vein for hydration, 31-60 minutes
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96523 Irrigation of implanted venous access drug delivery device
G0008 Administration of influenza virus vaccine
90662 Influenza vaccine split virus, preservative free
96361 Infusion into a vein for hydration, each additional hour
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.